The panograph in cancer patients receiving myelosuppressive chemotherapy.

被引:0
|
作者
Catanzano, J [1 ]
Weikel, D [1 ]
Favilla, E [1 ]
Elsabagh, A [1 ]
Overholser, C [1 ]
Meiller, T [1 ]
机构
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
关键词
D O I
暂无
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
11
引用
收藏
页码:107 / 107
页数:1
相关论文
共 50 条
  • [11] Population-based patterns of granulocyte colony stimulating factor (GCSF) use in breast cancer (BrCa) patients receiving myelosuppressive chemotherapy.
    Lehmkuhl, Michelle
    Chen, Leo
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [12] Economic analysis of prophylactic pegfilgrastim in cancer patients receiving chemotherapy.
    Eldar-Lissai, A
    Cosler, LE
    Lyman, GH
    BLOOD, 2004, 104 (11) : 608A - 608A
  • [13] Survival of metastatic metaplastic breast cancer patients receiving chemotherapy.
    Kukunoor, Sparsha
    Lee, Anna
    Taiwo, Evelyn Oluwatoyin
    Schreiber, David
    Luhrs, Carol A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [14] Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy
    Crawford, J
    PHARMACOTHERAPY, 2003, 23 (08): : 15S - 19S
  • [15] Patterns of granulocyte colony–stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy
    Prasad L. Gawade
    Shuling Li
    David Henry
    Nancy Smith
    Rajesh Belani
    Michael A. Kelsh
    Brian D. Bradbury
    Supportive Care in Cancer, 2020, 28 : 4413 - 4424
  • [16] Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim
    H. Xu
    Q. Gong
    F. D. Vogl
    M. Reiner
    J. H. Page
    Supportive Care in Cancer, 2016, 24 : 723 - 730
  • [17] Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy
    Andre, Nicolas
    El Kababri, Maria
    Bertrand, Pourroy
    Rome, Angelique
    Coze, Carole
    Gentet, Jean Claude
    Bernard, Jean Louis
    ANTI-CANCER DRUGS, 2007, 18 (03) : 277 - 281
  • [18] Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim
    Xu, H.
    Gong, Q.
    Vogl, F. D.
    Reiner, M.
    Page, J. H.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (02) : 723 - 730
  • [19] Patterns of fatigue and effect of exercise in breast cancer patients receiving chemotherapy.
    Wu, Horng-Shiuann
    Dodd, Marylin
    Cho, Maria
    ONCOLOGY NURSING FORUM, 2007, 34 (02) : 561 - 561
  • [20] Biodynamic response prediction in breast cancer patients receiving neoadjuvant chemotherapy.
    Morgan, Travis
    Whitacre, Eric
    Burak, William
    Manahan, Eric
    Goedde, Timothy
    Greenspan, Andrew
    Woods, John
    Nolte, David
    Turek, John
    Loesch, David M.
    An, Ran
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)